Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

407.83 20.58 +5.31%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 65.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, BeOne Medicines Ltd. - Sponsored ADR (ONC) trades at a P/B ratio of 7.5×. Over the past ten years it has ranged from 0.0× (March 2016) to 15.2× (September 2017); the current reading is higher than 74% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ONC/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BeOne Medicines Ltd. - Sponsored ADR P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ONC/metrics/pb-ratio">BeOne Medicines Ltd. - Sponsored ADR (ONC) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	7.6×	30.18%
FY2024	5.8×	11.74%
FY2023	5.2×	(2.04%)
FY2022	5.3×	30.08%
FY2021	4.1×	(26.46%)
FY2020	5.6×	(45.21%)
FY2019	10.2×	129.45%
FY2018	4.4×	(27.97%)
FY2017	6.2×	125.35%
FY2016	2.7×	—

Period	P/B ratio	Change
Sep 2026	7.0×	14.15%
Jun 2026	6.1×	(11.22%)
Mar 2026	6.9×	(8.89%)
Dec 2025	7.6×	(16.45%)
40 more quarters	Free account

Against its own ten years

Low 0.0× High 15.2×

Ten-year median 5.8×

Current reading's percentile 74

Company	P/B ratio
BNTX BioNTech SE Sponsored ADR compare	1.1×
RPRX Royalty Pharma PLC compare	3.1×
INCY Incyte Corporation compare	4.3×
ROIV Roivant Sciences Ltd. compare	5.4×
GMAB Genmab A/S Sponsored ADR compare	5.5×
ARGX argenex SE compare	6.7×
ONC BeOne Medicines Ltd. - Sponsored ADR	7.5×
RVMD Revolution Medicines, Inc. compare	16.1×
INSM Insmed, Inc. compare	32.6×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ONC

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ONC

Stockrow Weekly